EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023
CAMBRIDGE, Mass., April 27, 2023 (GLOBE NEWSWIRE) — EQRx, Inc. (Nasdaq:EQRX), a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions, today announced it will host a conference call and webcast on Monday, May 8, 2023, at 4:30 p.m. ET to report its first quarter 2023 financial results and provide a business update.
Related news for (EQRX)
- EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. – EQRX
- EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. – EQRX
- EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference